X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet   (REDY)

Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 2,573.5
Mkt Cap Rs m 426,446
Vol '000 31.3
P/E X 31.6
P/CF X 21.4
EPS (TTM) Rs 81.3
% ch % 0.5
No. of shares m 165.71
% ch week % 5.2
% ch 1-mth % 0.2
% ch 12-mth % 7.4
52 week H/L Rs 2,687.5/1,888.0
(As on Oct 16, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs2,9403,6624,3833,3972,788 
Low Rs1,7662,2502,7502,5601,902 
Sales per share (Unadj.) Rs788.6881.8912.5856.5860.8 
Earnings per share (Unadj.) Rs115.4137.1124.978.057.1 
Diluted earnings per shareRs118.5141.0128.678.057.1 
Cash flow per share (Unadj.) Rs153.5181.7179.9139.9122.0 
Dividends per share (Unadj.) Rs18.0020.0020.0020.0020.00 
Adj. dividends per shareRs18.4820.5620.5920.0020.02 
Dividend yield (eoy) %0.80.70.60.70.9 
Book value per share (Unadj.) Rs462.4635.8736.8739.8757.7 
Adj. book value per shareRs474.6653.8758.5740.0758.7 
Shares outstanding (eoy) m170.11170.38170.61165.74165.91 
Bonus/Rights/Conversions  ESOPESOPESOPBBESOP 
Price / Sales ratio x3.03.43.93.52.7 
Avg P/E ratio x20.421.628.638.241.1 
P/CF ratio (eoy) x15.316.319.821.319.2 
Price / Book Value ratio x5.14.64.84.03.1 
Dividend payout %15.614.616.025.735.0 
Avg Mkt Cap Rs m400,277503,643608,481493,632389,034 
No. of employees `00019.019.921.722.723.5 
Total wages/salary Rs m24,75429,44631,17431,06832,149 
Avg. sales/employee Rs Th7,060.77,565.77,184.66,259.06,070.8 
Avg. wages/employee Rs Th1,302.81,482.91,438.61,369.81,366.6 
Avg. net profit/employee Rs Th1,033.31,176.6983.2569.7402.5 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m134,153150,233155,683141,961142,810 
Other income Rs m1,6972,7412,9501,7151,552 
Total revenues Rs m135,850152,974158,633143,676144,362 
Gross profit Rs m32,50834,93635,85324,72223,512 
Depreciation Rs m6,4757,5999,38910,26610,772 
Interest Rs m1,2671,082826634788 
Profit before tax Rs m26,46328,99628,58815,53713,504 
Minority Interest Rs m00000 
Prior Period Items Rs m00229349344 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6,8315,6327,5112,9654,380 
Profit after tax Rs m19,63223,36421,30612,9219,468 
Gross profit margin %24.223.323.017.416.5 
Effective tax rate %25.819.426.319.132.4 
Net profit margin %14.615.613.79.16.6 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m103,257118,096117,94096,837104,984 
Current liabilities Rs m57,90463,73463,47184,19968,938 
Net working cap to sales %33.836.235.08.925.2 
Current ratio x1.81.91.91.21.5 
Inventory Days Days6662607374 
Debtors Days Days90999798104 
Net fixed assets Rs m52,79659,06573,352102,552104,385 
Share capital Rs m851852853829830 
"Free" reserves Rs m72,946107,482124,845121,792124,886 
Net worth Rs m78,652108,334125,698122,621125,716 
Long term debt Rs m20,75514,30710,6855,44925,089 
Total assets Rs m160,296190,650203,841218,165225,443 
Interest coverage x21.927.835.625.518.1 
Debt to equity ratio x0.30.10.100.2 
Sales to assets ratio x0.80.80.80.70.6 
Return on assets %13.012.810.96.24.5 
Return on equity %25.021.617.010.57.5 
Return on capital %27.924.521.712.99.7 
Exports to sales %55.249.446.654.60 
Imports to sales %8.99.09.09.40 
Exports (fob) Rs m74,05974,14672,61877,5200 
Imports (cif) Rs m11,95913,48514,05013,2740 
Fx inflow Rs m76,00774,87075,40581,67072,623 
Fx outflow Rs m24,60726,00827,11526,35518,916 
Net fx Rs m51,40048,86248,29055,31553,707 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 19,697 25,235 32,626 21,444 18,030 
From Investments Rs m -16,941 -22,647 -20,394 -18,404 -14,883 
From Financial Activity Rs m -242 -4,332 -17,001 -3,692 -4,440 
Net Cashflow Rs m 2,514 -1,744 -474 -1,144 -1,236 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES  BIOCON LTD  WOCKHARDT LTD.  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES  BIOCON LTD  WOCKHARDT LTD.  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 297 Points Higher; Energy and Realty Stocks Witness Buying(Closing)

Share markets in India continued their momentum during closing hours and ended the day on a positive note. Sectoral indices were trading on a positive note, with stocks in the energy sector.

Views on news

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Don't Panic in This Falling Market... Do This Instead(The 5 Minute Wrapup)

Oct 5, 2018

Find companies with long term durable moats, which are correcting with the current broader market sell-off.

Why You Should Be Excited, Not Sad, About the 30% Small Cap Crash(Profit Hunter)

Oct 4, 2018

Smallcaps have corrected over 30% since the beginning of the year. Find out why Richa Agarwal views this as an opportunity rather than a threat.

Taxpayers to pay salaries of CEOs/CIOs of Mutual Funds(The Honest Truth)

Oct 5, 2018

Ajit Dayal on the crisis in the market and in the mutual fund industry.

Why Are Investors In Sundaram Small Cap Fund Anxious(Outside View)

Oct 3, 2018

A small cap fund that aims to capitalise on emerging businesses and catch them young. However, its failure in keeping volatility under check is making its investors anxious.

Biggest Corrections in the Stock of Infibeam Avenues(Chart Of The Day)

Oct 3, 2018

Infibeam plunged over 70% last week. This was the second biggest single-day fall. But Infibeam witnessed such sharp falls earlier.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - ACTAVIS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS